Mechanism and regulation of human intestinal niacin uptake.
The mechanism of uptake of dietary niacin (nicotinic acid) by intestinal epithelial cells is not well understood, and nothing is known about regulation of the uptake process. In this investigation, we used human-derived intestinal epithelial Caco-2 cells and purified intestinal brush-border membrane vesicles (BBMVs) isolated from human organ donors to assess niacin uptake. Our findings show niacin uptake by Caco-2 cells to be 1) temperature and energy dependent; 2) Na+ independent, but highly dependent on extracellular acidic pH; 3) saturable as a function of concentration, with an apparent K(m) of 0.53 +/- 0.08 microM; 4) severely inhibited by the membrane-impermeable sulfhydryl group of reagents; and 5) highly specific for niacin but not affected by monocarboxylic acids. A marked trans stimulation in [3H]niacin efflux from preloaded Caco-2 cells by unlabeled niacin in the incubation buffer was also observed. These findings suggest the involvement of a specialized, pH-dependent, carrier-mediated mechanism for human intestinal niacin uptake. This suggestion was confirmed in studies with native human intestinal BBMVs. We also examined possible regulation of niacin uptake by Caco-2 cells via specific intracellular regulatory pathways. The results show that while the PKA-, PKC-, and Ca2+/calmodulin-mediated regulatory pathways play no role in regulating niacin uptake, a role for a protein tyrosine kinase (PTK)-mediated pathway is apparent. The results of these studies show for the first time the existence of a specialized, acidic pH-dependent, carrier-mediated system of niacin uptake by human intestinal epithelial cells that operates at the micromolar (physiological) range of niacin. The results also suggest the possible involvement of a PTK-mediated pathway in the regulation of niacin uptake.
Nabokina
Svetlana M
SM
Veterans Affairs Healthcare System, Long Beach, California 90822, USA.
Kashyap
Moti L
ML
Said
Hamid M
HM
D018938:Caco-2 Cells; D002264:Carboxylic Acids / Q000494:pharmacology; D002352:Carrier Proteins / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism*; D049990:Membrane Transport Modulators; D026901:Membrane Transport Proteins / Q000037:antagonists & inhibitors; D008871:Microvilli / Q000378:metabolism; D009525:Niacin / Q000493:pharmacokinetics*; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D002264:Carboxylic Acids; D002352:Carrier Proteins; D049990:Membrane Transport Modulators; D026901:Membrane Transport Proteins; D013438:Sulfhydryl Compounds; D009525:Niacin